Motta A et al. |
Immunohistopathological characterization and the impact of topical immunomodulatory therapy in oral chronic graft-versus-host disease: A pilot study. |
2018 |
Oral Dis |
pmid:29197137
|
Bae SC and Lee YH |
Comparative efficacy and tolerability of monotherapy with leflunomide or tacrolimus for the treatment of rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials. |
2018 |
Clin. Rheumatol. |
pmid:28967035
|
González-VÃlchez F et al. |
Efficacy and Safety of de Novo and Early Use of Extended-release Tacrolimus in Heart Transplantation. |
2018 |
Rev Esp Cardiol (Engl Ed) |
pmid:28545984
|
Al-Lawati H et al. |
Nanomedicine for immunosuppressive therapy: achievements in pre-clinical and clinical research. |
2018 |
Expert Opin Drug Deliv |
pmid:29261332
|
Thoms S et al. |
Tacrolimus inhibits angiogenesis and induces disaggregation of endothelial cells in spheroids - Toxicity testing in a 3D cell culture approach. |
2018 |
Toxicol In Vitro |
pmid:30048735
|
Htun YY et al. |
CYP3A5*3 Genetic Polymorphism and Tacrolimus Concentration in Myanmar Renal Transplant Patients. |
2018 |
Transplant. Proc. |
pmid:29731062
|
Hu R et al. |
CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose-adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post-Kidney Transplantation. |
2018 |
Basic Clin. Pharmacol. Toxicol. |
pmid:29603629
|
Mücke VT et al. |
Low Serum Levels of (Dihydro-)Ceramides Reflect Liver Graft Dysfunction in a Real-World Cohort of Patients Post Liver Transplantation. |
2018 |
Int J Mol Sci |
pmid:29587453
|
Davidson HE |
Shifting Paradigms in Caring for Older Adults. |
2018 |
Consult Pharm |
pmid:29789044
|
Pircher C et al. |
A rare case of Epstein-Barr virus-associated hepatosplenic smooth muscle tumors after kidney transplantation. |
2018 |
Transpl Infect Dis |
pmid:29427352
|